The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Construction and Characterization of Virus-Like Particles: A Review
Open accessAbstract
Over the last three decades, virus-like particles (VLPs) have evolved to become a widely accepted technology, especially in the field of vaccinology. In fact, some VLP-based vaccines are currently used as commercial medical products, and other VLP-based products are at different stages of clinical study. Several remarkable advantages have been achieved in the development of VLPs as gene therapy tools and new nanomaterials. The analysis of published data reveals that at least 110 VLPs have been constructed from viruses belonging to 35 different families. This review therefore discusses the main principles in the cloning of viral structural genes, the relevant host systems and the purification procedures that have been developed. In addition, the methods that are used to characterize the structural integrity, stability, and components, including the encapsidated nucleic acids, of newly synthesized VLPs are analyzed. Moreover, some of the modifications that are required to construct VLP-based carriers of viral origin with defined properties are discussed, and examples are provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Indian Journal of Experimental Biology
(2022) · Indian Journal of Experimental Biology · doi:10.56042/ijeb · Cited by 3,392
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Biopharmaceutical benchmarks 2014
Walsh, G. (2014) · Nature Biotechnology · doi:10.1038/nbt.3040 · Cited by 1,008
RNAi-Mediated Chromatin Silencing in Fission Yeast
White, S. A., & Allshire, R. C. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75157-1_8 · Cited by 971
Synthesis and assembly of hepatitis B virus surface antigen particles in yeast
Valenzuela, P., Medina, A., Rutter, W. J., Ammerer, G., & Hall, B. D. (1982) · Nature · doi:10.1038/298347a0 · Cited by 877
Virus-like particles in vaccine development
Roldão, A., Mellado, M. C. M., Castilho, L. R., Carrondo, M. J., & Alves, P. M. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.115 · Cited by 845
The Influence of Antigen Organization on B Cell Responsiveness
Bachmann, M. F., Rohrer, U. H., Kündig, T. M., Bürki, K., Hengartner, H., & Zinkernagel, R. M. (1993) · Science · doi:10.1126/science.8248784 · Cited by 717
Cell-free protein synthesis: Applications come of age
Carlson, E. D., Gan, R., Hodgman, C. E., & Jewett, M. C. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.09.016 · Cited by 706
Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography
Voss, J. E., Vaney, M.-C., Duquerroy, S., Vonrhein, C., Girard-Blanc, C., Crublet, E., Thompson, A., Bricogne, G., & Rey, F. A. (2010) · Nature · doi:10.1038/nature09555 · Cited by 696
Metagenomics and future perspectives in virus discovery
Mokili, J. L., Rohwer, F., & Dutilh, B. E. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.12.004 · Cited by 662
Akahata, W., Yang, Z.-Y., Andersen, H., Sun, S., Holdaway, H. A., Kong, W.-P., Lewis, M. G., Higgs, S., Rossmann, M. G., Rao, S., et al. (2010) · Nature Medicine · doi:10.1038/nm.2105 · Cited by 515
Structure of Small Virus-like Particles Assembled from the L1 Protein of Human Papillomavirus 16
Chen, X. S., Garcea, R. L., Goldberg, I., Casini, G., & Harrison, S. C. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80449-9 · Cited by 471
NEUTRALIZING ANTIVIRAL B CELL RESPONSES
Bachmann, M. F., & Zinkernagel, R. M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.235 · Cited by 471
ViralZone: a knowledge resource to understand virus diversity
Hulo, C., de Castro, E., Masson, P., Bougueleret, L., Bairoch, A., Xenarios, I., & Le Mercier, P. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq901 · Cited by 452
Viral vectors for the expression of proteins in plants
Gleba, Y., Klimyuk, V., & Marillonnet, S. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.03.002 · Cited by 435
Prevention of cervical cancer through papillomavirus vaccination
Frazer, I. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1260 · Cited by 402
Biopharmaceutical benchmarks 2006
Walsh, G. (2006) · Nature Biotechnology · doi:10.1038/nbt0706-769 · Cited by 359
Plant‐made vaccines for humans and animals
Rybicki, E. P. (2010) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2010.00507.x · Cited by 334
Modern Uses of Electron Microscopy for Detection of Viruses
Goldsmith, C. S., & Miller, S. E. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00027-09 · Cited by 330
Biological Gene Delivery Vehicles: Beyond Viral Vectors
Seow, Y., & Wood, M. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.41 · Cited by 327
Storni, T., Ruedl, C., Schwarz, K., Schwendener, R. A., Renner, W. A., & Bachmann, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1777 · Cited by 286
Large-scale production and purification of VLP-based vaccines
Vicente, T., Roldão, A., Peixoto, C., Carrondo, M. J. T., & Alves, P. M. (2011) · Journal of Invertebrate Pathology · doi:10.1016/j.jip.2011.05.004 · Cited by 270
PUSHKO, P., TUMPEY, T., BU, F., KNELL, J., ROBINSON, R., & SMITH, G. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.098 · Cited by 249
Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle
Fuller, S. D., Wilk, T., Gowen, B. E., Kräusslich, H.-G., & Vogt, V. M. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00331-9 · Cited by 247
Ebola virus-like particles protect from lethal Ebola virus infection
Warfield, K. L., Bosio, C. M., Welcher, B. C., Deal, E. M., Mohamadzadeh, M., Schmaljohn, A., Aman, M. J., & Bavari, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237038100 · Cited by 244
Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322
Burrell, C. J., Mackay, P., Greenaway, P. J., Hofschneider, P. H., & Murray, K. (1979) · Nature · doi:10.1038/279043a0 · Cited by 241
Conformational Stability and Disassembly of Norwalk Virus-like Particles
Ausar, S. F., Foubert, T. R., Hudson, M. H., Vedvick, T. S., & Middaugh, C. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603313200 · Cited by 241
Protein delivery using engineered virus-like particles
Kaczmarczyk, S. J., Sitaraman, K., Young, H. A., Hughes, S. H., & Chatterjee, D. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101874108 · Cited by 219
Enzymatic lysis of microbial cells
Salazar, O., & Asenjo, J. A. (2007) · Biotechnology Letters · doi:10.1007/s10529-007-9345-2 · Cited by 217
Controlled Encapsulation of Multiple Proteins in Virus Capsids
Minten, I. J., Hendriks, L. J. A., Nolte, R. J. M., & Cornelissen, J. J. L. M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907843s · Cited by 204
Patel, K. G., & Swartz, J. R. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100367u · Cited by 182
Towards the preparative and large-scale precision manufacture of virus-like particles
Pattenden, L. K., Middelberg, A. P. J., Niebert, M., & Lipin, D. I. (2005) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.07.011 · Cited by 177
A highly sensitive and selective diagnostic assay based on virus nanoparticles
Park, J.-S., Cho, M. K., Lee, E. J., Ahn, K.-Y., Lee, K. E., Jung, J. H., Cho, Y., Han, S.-S., Kim, Y. K., & Lee, J. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.38 · Cited by 164
Electron microscopy of hepatitis B core antigen synthesized in E. coli
Cohen, B. J., & Richmond, J. E. (1982) · Nature · doi:10.1038/296677a0 · Cited by 162
Zhao, X., Fox, J. M., Olson, N. H., Baker, T. S., & Young, M. J. (1995) · Virology · doi:10.1006/viro.1995.1108 · Cited by 161
Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris
Hardy, E., Martı́nez, E., Diago, D., Díaz, R., González, D., & Herrera, L. (2000) · Journal of Biotechnology · doi:10.1016/s0168-1656(99)00201-1 · Cited by 156
Krol, M. A., Olson, N. H., Tate, J. G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13650 · Cited by 155
Chemical Modification of Viruses and Virus-Like Particles
Strable, E., & Finn, M. G. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-69379-6_1 · Cited by 151
Virus hybrids as nanomaterials for biotechnology
Soto, C. M., & Ratna, B. R. (2010) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.07.004 · Cited by 136
Hofmann, K. J., Cook, J. C., Joyce, J. G., et al. (1995) · Virology · doi:10.1006/viro.1995.1283 · Cited by 134
Hoenen, T., Groseth, A., de Kok-Mercado, F., Kuhn, J. H., & Wahl‐Jensen, V. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.06.003 · Cited by 131
Newcomb, W. W., Homa, F. L., Thomsen, D. R., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4239-4250.1999 · Cited by 130
Viruses and virus-like protein assemblies—Chemically programmable nanoscale building blocks
Lee, L. A., Niu, Z., & Wang, Q. (2009) · Nano Research · doi:10.1007/s12274-009-9033-8 · Cited by 125
White, L., Hardy, M. E., & Estes, M. K. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.8066-8072.1997 · Cited by 123
Therapeutic vaccination for chronic diseases: a new class of drugs in sight
Bachmann, M. F., & Dyer, M. R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1284 · Cited by 115
Efficient disulfide bond formation in virus-like particles
Bundy, B. C., & Swartz, J. R. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.04.011 · Cited by 113
Mammalian Expression of Virus-Like Particles for Advanced Mimicry of Authentic Influenza Virus
Wu, C.-Y., Yeh, Y.-C., Yang, Y., Chou, C., Liu, M., Wu, H.-S., Chan, J.-T., & Hsiao, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009784 · Cited by 112
Host RNAs, including transposons, are encapsidated by a eukaryotic single-stranded RNA virus
Routh, A. L., Domitrovic, T., & Johnson, J. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116168109 · Cited by 112
Zhao, Q., Modis, Y., High, K., Towne, V., Yuan, M., Wang, Y., Alexandroff, J., Brown, M. J., Carragher, B. O., Potter, C. S., et al. (2012) · Virology Journal · doi:10.1186/1743-422x-9-52 · Cited by 111
Spohn, G., Guler, R., Johansen, P., Keller, I., Jacobs, M., Beck, M., Röhner, F., Bauer, M., Dietmeier, K., Kündig, T. M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7450 · Cited by 110
Spohn, G., Jennings, G. T., Martina, B. E. E., Keller, I., Beck, M., Pumpens, P., Osterhaus, A. D. M. E., & Bachmann, M. F. (2010) · Virology Journal · doi:10.1186/1743-422x-7-146 · Cited by 99
Sokolenko, S., George, S., Wagner, A., Tuladhar, A., Andrich, J. M. S., & Aucoin, M. G. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.01.009 · Cited by 96
Walker, A., Skamel, C., & Nassal, M. (2011) · Scientific Reports · doi:10.1038/srep00005 · Cited by 94
Expression, purification and characterization of enterovirus-71 virus-like particles
Chung, Y.-C., Huang, J., Lai, C., Sheng, H.-C., Shih, S.-R., Ho, M.-S., & Hu, Y.-C. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i6.921 · Cited by 93
Virus scaffolds as enzyme nano-carriers
Cardinale, D., Carette, N., & Michon, T. (2012) · Trends in biotechnology · doi:10.1016/j.tibtech.2012.04.001 · Cited by 93
Lünsdorf, H., Gurramkonda, C., Adnan, A., Khanna, N., & Rinas, U. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-48 · Cited by 92
Peptide-mediated DNA condensation for non-viral gene therapy
Saccardo, P., Villaverde, A., & González‐Montalbán, N. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2009.03.004 · Cited by 85
A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines
Middelberg, A. P. J., Rivera-Hernández, T., Wibowo, N., Lua, L. H. L., Fan, Y., Magor, G. W., Chang, C. J., Chuan, Y. P., Good, M. F., & Batzloff, M. R. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.075 · Cited by 83
Burns, N. R., Saibil, H. R., White, N., Pardon, J. F., Timmins, P. A., Richardson, S. M., Richards, B. M., Adams, S. E., Kingsman, S. M., & Kingsman, A. J. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05156.x · Cited by 82
Haynes, J. R., Cunningham, J., von Seefried, A., Lennick, M., Garvin, R. T., & Shen, S.-H. (1986) · Nature Biotechnology · doi:10.1038/nbt0786-637 · Cited by 80
[12] Preparation of extracts from prokaryotes
Cull, M. G., & McHenry, C. S. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)82014-s · Cited by 78
Vaccine Potential of Nipah Virus-Like Particles
Walpita, P., Barr, J. A., Sherman, M. B., Basler, C. F., & Wang, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018437 · Cited by 76
Current strategies for subunit and genetic viral veterinary vaccine development
Brun, A., Bárcena, J., Blanco, E., Borrego, B., Dory, D., Escribano, J. M., Gall-Reculé, G. L., Ortego, J., & Dixon, L. K. (2011) · Virus Research · doi:10.1016/j.virusres.2011.02.006 · Cited by 74
Mutilation of RNA phage Qβ virus‐like particles: from icosahedrons to rods
Cielēns, I., Ose, V., Petrovskis, I., Zajakina, A., Renhofa, R., Kozlovska, T. M., & Pumpens, P. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02061-5 · Cited by 73
Bunka, D. H. J., Lane, S. W., Lane, C. L., Dykeman, E. C., Ford, R. J., Barker, A., Twarock, R., Phillips, S. E. V., & Stockley, P. G. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.07.063 · Cited by 71
Therapeutic vaccines for chronic diseases: successes and technical challenges
Bachmann, M. F., & Jennings, G. T. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0103 · Cited by 70
Vicente, T., Mota, J. P. B., Peixoto, C., Alves, P. M., & Carrondo, M. J. T. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.07.004 · Cited by 69
Size and mechanical stability of norovirus capsids depend on pH: a nanoindentation study
Cuellar‐Camacho, J. L., Meinhoevel, F., Hoehne, M., & Donath, E. (2010) · Journal of General Virology · doi:10.1099/vir.0.021212-0 · Cited by 69
Rational Design of a Stable, Freeze-Dried Virus-Like Particle-Based Vaccine Formulation
Lang, R., Winter, G., Vogt, L., Zürcher, A., Dorigo, B., & Schimmele, B. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802192806 · Cited by 67
Lu, X., Chen, Y., Bai, B., Hu, H., Tao, L., Yang, J., Chen, J., Chen, Z., Hú, Z., & Wang, H. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02676.x · Cited by 63
Saliki, J. T., Mizak, B., Flore, H., Gettig, R. R., Burand, J. P., Carmichael, L. E., Wood, H. A., & Parrish, C. R. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-2-369 · Cited by 60
Luo, L., Li, Y., & Kang, C. Y. (1990) · Virology · doi:10.1016/0042-6822(90)90159-o · Cited by 56
Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris
Freivalds, J., Dišlers, A., Ose, V., Pumpens, P., Tārs, K., & Kazāks, A. (2010) · Protein Expression and Purification · doi:10.1016/j.pep.2010.09.010 · Cited by 55
Plant-Based Oral Vaccines: Results of Human Trials
Tacket, C. O. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-70868-1_6 · Cited by 55
High-level expression of soluble viral structural protein in Escherichia coli
Chuan, Y. P., Lua, L. H. L., & Middelberg, A. P. J. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.12.004 · Cited by 54
Mena, I., Vivó, A., Pérez, E., & Portela, A. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5016-5024.1996 · Cited by 53
Human parvovirus B19 virus-like particles: In vitro assembly and stability
Sánchez-Rodríguez, S. P., Münch-Anguiano, L., Echeverría, O. M., Vázquez‐Nin, G. H., Mora‐Pale, M., Dordick, J. S., & Bustos‐Jaimes, I. (2011) · Biochimie · doi:10.1016/j.biochi.2011.12.006 · Cited by 52
Smith, M. T., Varner, C., Bush, D. B., & Bundy, B. C. (2011) · Biotechnology Progress · doi:10.1002/btpr.744 · Cited by 45
Ju, H., Wei, N., Wang, Q., Wang, C., Jing, Z., Guo, L., Liu, D., Gao, M., Ma, B., & Wang, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.129 · Cited by 43
Production of FMDV virus-like particles by a SUMO fusion protein approach in Escherichia coli
Lee, C., Yan, Y.-P., Liang, S., & Wang, T. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-69 · Cited by 42
Freivalds, J., Dišlers, A., Ose, V., Skrastiņa, D., Cielēns, I., Pumpens, P., Sasnauskas, K., & Kazāks, A. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.11.013 · Cited by 40
Pastori, C., Tudor, D., Diomede, L., Drillet, A.-S., Jegerlehner, A., Röhn, T. A., Bomsel, M., & Lopalco, L. (2012) · Virology · doi:10.1016/j.virol.2012.05.005 · Cited by 35
Using Polymer Conformation to Control Architecture in Semiconducting Polymer/Viral Capsid Assemblies
Ng, B. C., Chan, S. T., Lin, J. Y., & Tolbert, S. H. (2011) · ACS Nano · doi:10.1021/nn202493w · Cited by 34
Lamb, J. W., Duncan, G. H., Reavy, B., Gildow, F. E., Mayo, M. A., & Hay, R. T. (1996) · Journal of General Virology · doi:10.1099/0022-1317-77-7-1349 · Cited by 32
Plevka, P., Kazāks, A., Voronkova, T., Koteloviča, S., Dišlers, A., Liljas, L., & Tārs, K. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.06.047 · Cited by 30
H1N1 Influenza Virus-Like Particles: Physical Degradation Pathways and Identification of Stabilizers
Kissmann, J. M., Joshi, S. B., Haynes, J. R., Dokken, L., Richardson, C., & Middaugh, C. R. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22304 · Cited by 30
Artificial Genes for Chimeric Virus-Like Particles
Khudyakov, Y. E., & Fields, H. A. (2002) · CRC Press eBooks · doi:10.1201/9781420040166-12 · Cited by 28
Low pH‐Triggered Model Drug Molecule Release from Virus‐Like Particles
Ohtake, N., Niikura, K., Suzuki, T., Nagakawa, K., Mikuni, S., Matsuo, Y., Kinjo, M., Sawa, H., & Ijiro, K. (2010) · ChemBioChem · doi:10.1002/cbic.201000094 · Cited by 25
The Capsid of the Small RNA Phage PRR1 Is Stabilized by Metal Ions
Persson, M., Tārs, K., & Liljas, L. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.08.060 · Cited by 23
Analysis of the size of DNA packaged by the human JC virus-like particle
Fang, C., Lin, P. Y., Ou, W., Chen, P., Shen, C., Chang, D., & Wang, M. (2012) · Journal of Virological Methods · doi:10.1016/j.jviromet.2012.03.017 · Cited by 22
Defect of Human Immunodeficiency Virus Type 2 Gag Assembly in Saccharomyces cerevisiae
Morikawa, Y., Goto, T., Yasuoka, D., Momose, F., & Matano, T. (2007) · Journal of Virology · doi:10.1128/jvi.00027-07 · Cited by 21
Powilleit, F., Breinig, T., & Schmitt, M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000415 · Cited by 20
Rumnieks, J., Ose, V., Tārs, K., Dišlers, A., Strods, A., Cielēns, I., & Renhofa, R. (2009) · Virology · doi:10.1016/j.virol.2009.06.023 · Cited by 12
Crowther, R. A. (2010) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-381357-2.00001-3 · Cited by 10
Cited by
Strategies for delivering therapeutics across the blood–brain barrier
Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138
Nooraei, S., Bahrulolum, H., Hoseini, Z. S., Katalani, C., Hajizade, A., Easton, A. J., & Ahmadian, G. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00806-7 · Cited by 869
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts
Stewart, M. P., Langer, R., & Jensen, K. F. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00678 · Cited by 747
Vaccine delivery using nanoparticles
Gregory, A. E., Titball, R., & Williamson, D. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00013 · Cited by 561
Metadata
- Authors
- Zeltins, A.
- Venue
- Molecular Biotechnology
- Published
- 2012-09-24
- Volume
- 53
- Issue
- 1
- Pages
- 92-107
- ISSN
- 1073-6085 (ISSN-L)
- 1559-0305
- OpenAlex
- W2056036907
- Cited by
- 478
- References
- 96
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.